Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
5 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
ESAB (NYSE: ESAB ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary ESAB Corporation reported a strong second quarter 2026, with re
Bank Of England Holds Rates Warning Of Hike If War Continues BoE Sets Out Long-Term Plan To Unwind QE, Halts Long-Dated Gilt Sales Trump Is To Hold Talks With Gulf Leaders Next Week On Iran Trump Hopes Iran War Nearing End As Houthi-Saudi Fighting Escalates Trump Derides EU Pitch To Canada As 'Laughable', Threatens Mor
U.S. Trade Representative Jamieson Greer said Germany's proposal to reduce spending on medicines was "a serious step backwards."
The U.S. said the probe will examine whether "persistent underpayment" for medicines by Germany is discriminatory. "President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development," said U.S. Trade Representative Jamieson Greer.
The U.S. said the probe will examine whether "persistent underpayment" for medicines by Germany is discriminatory. "President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development," said U.S. Trade Representative Jamieson Greer.